Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Berocca is a multivitamin and mineral dietary supplement manufactured by Bayer. It is formulated as a combination of B-complex vitamins (including thiamine, riboflavin, nicotinamide, pantothenic acid, pyridoxine, cyanocobalamin, biotin, and folic acid), vitamin C (ascorbic acid), and essential minerals such as calcium, magnesium, and zinc. Primarily available as effervescent or film-coated tablets, it is marketed to support physical and mental energy levels and to prevent or treat deficiencies of these nutrients, particularly during periods of stress or fatigue. As a dietary supplement, it is not indicated for the treatment of specific diseases in a pharmaceutical sense and is available over-the-counter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Berocca.